Clinical Trial Update: Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial update reports on sofosbuvir-containing regimens for chronic hepatitis C infection, genotype 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Humanity and Health Research Centre | Conditions: Chronic Hepatitis C Infection | Phase 4 | Status: COMPLETED